24050620|t|Methylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cells.
24050620|a|BACKGROUND: Increased levels of the sugar metabolite methylglyoxal (MG) in vivo were shown to participate in the pathophysiology of vascular complications in diabetes. Alterations of endothelial nitric oxide synthase (eNOS) activity by hypophosphorylation of the enzyme and enhanced monomerization are found in the diabetic milieu, and the regulation of this still remains undefined. Using various pharmacological approaches, we elucidate putative mechanisms by which MG modulates eNOS-associated functions of MG-stimulated superoxide O2 - production, phosphorylation status and eNOS uncoupling in EA.hy926 human endothelial cells. METHODS: In cultured EA.hy926 endothelial cells, the effects of MG treatment, tetrahydrobiopterin (BH4; 100 muM) and sepiapterin (20 muM) supplementation, NOS inhibition by N(G)-nitro-L-arginine methyl ester (L-NAME; 50 muM), and inhibition of peroxynitrite (ONOO-) formation (300 muM Tempol plus 50 muM L-NAME) on eNOS dimer/monomer ratios, Ser-1177 eNOS phosphorylation and 3-nitrotyrosine (3NT) abundance were quantified using immunoblotting. O2 --dependent fluorescence was determined using a commercially available kit and tissue biopterin levels were measured by fluorometric HPLC analysis. RESULTS: In EA.hy926 cells, MG treatment significantly enhanced O2 - generation and 3NT expression and reduced Ser-1177 eNOS phosphorylation, eNOS dimer/monomer ratio and cellular biopterin levels indicative of eNOS uncoupling. These effects were significantly mitigated by administration of BH4, sepiapterin and suppression of ONOO- formation. L-NAME treatment significantly blunted eNOS-derived O2 - generation but did not modify eNOS phosphorylation or monomerization. CONCLUSION: MG triggers eNOS uncoupling and hypophosphorylation in EA.hy926 endothelial cells associated with O2 - generation and biopterin depletion. The observed effects of the glycolysis metabolite MG presumably account, at least in part, for endothelial dysfunction in diabetes.
24050620	0	13	Methylglyoxal	Chemical	MESH:D011765
24050620	24	57	endothelial nitric oxide synthase	Gene	4846
24050620	82	90	EA.hy926	CellLine	CVCL:3901
24050620	146	151	sugar	Chemical	MESH:D000073893
24050620	163	176	methylglyoxal	Chemical	MESH:D011765
24050620	178	180	MG	Chemical	MESH:D011765
24050620	242	264	vascular complications	Disease	MESH:D003925
24050620	268	276	diabetes	Disease	MESH:D003920
24050620	293	326	endothelial nitric oxide synthase	Gene	4846
24050620	328	332	eNOS	Gene	4846
24050620	425	433	diabetic	Disease	MESH:D003920
24050620	578	580	MG	Chemical	MESH:D011765
24050620	591	595	eNOS	Gene	4846
24050620	620	622	MG	Chemical	MESH:D011765
24050620	634	644	superoxide	Chemical	MESH:D013481
24050620	645	649	O2 -	Chemical	MESH:D013481
24050620	689	693	eNOS	Gene	4846
24050620	708	716	EA.hy926	CellLine	CVCL:3901
24050620	717	722	human	Species	9606
24050620	763	771	EA.hy926	CellLine	CVCL:3901
24050620	806	808	MG	Chemical	MESH:D011765
24050620	820	839	tetrahydrobiopterin	Chemical	MESH:C003402
24050620	841	844	BH4	Chemical	MESH:C003402
24050620	859	870	sepiapterin	Chemical	MESH:C016727
24050620	915	949	N(G)-nitro-L-arginine methyl ester	Chemical	MESH:D019331
24050620	951	957	L-NAME	Chemical	MESH:D019331
24050620	986	999	peroxynitrite	Chemical	MESH:D030421
24050620	1001	1006	ONOO-	Chemical	-
24050620	1027	1033	Tempol	Chemical	MESH:C001803
24050620	1046	1052	L-NAME	Chemical	MESH:D019331
24050620	1057	1061	eNOS	Gene	4846
24050620	1093	1097	eNOS	Gene	4846
24050620	1118	1133	3-nitrotyrosine	Chemical	MESH:C002744
24050620	1135	1138	3NT	Chemical	MESH:C002744
24050620	1188	1192	O2 -	Chemical	MESH:D013481
24050620	1277	1286	biopterin	Chemical	MESH:D001708
24050620	1351	1359	EA.hy926	CellLine	CVCL:3901
24050620	1367	1369	MG	Chemical	MESH:D011765
24050620	1403	1407	O2 -	Chemical	MESH:D013481
24050620	1423	1426	3NT	Chemical	MESH:C002744
24050620	1459	1463	eNOS	Gene	4846
24050620	1481	1485	eNOS	Gene	4846
24050620	1519	1528	biopterin	Chemical	MESH:D001708
24050620	1550	1554	eNOS	Gene	4846
24050620	1631	1634	BH4	Chemical	MESH:C003402
24050620	1636	1647	sepiapterin	Chemical	MESH:C016727
24050620	1667	1672	ONOO-	Chemical	-
24050620	1684	1690	L-NAME	Chemical	MESH:D019331
24050620	1723	1727	eNOS	Gene	4846
24050620	1736	1740	O2 -	Chemical	MESH:D013481
24050620	1771	1775	eNOS	Gene	4846
24050620	1823	1825	MG	Chemical	MESH:D011765
24050620	1835	1839	eNOS	Gene	4846
24050620	1878	1886	EA.hy926	CellLine	CVCL:3901
24050620	1921	1925	O2 -	Chemical	MESH:D013481
24050620	1941	1950	biopterin	Chemical	MESH:D001708
24050620	2012	2014	MG	Chemical	MESH:D011765
24050620	2057	2080	endothelial dysfunction	Disease	MESH:D014652
24050620	2084	2092	diabetes	Disease	MESH:D003920
24050620	Association	MESH:D003920	4846
24050620	Negative_Correlation	MESH:D001708	MESH:D011765
24050620	Positive_Correlation	MESH:D011765	MESH:D014652
24050620	Positive_Correlation	MESH:D011765	MESH:D003920
24050620	Negative_Correlation	MESH:D013481	MESH:D019331
24050620	Negative_Correlation	MESH:D011765	4846
24050620	Association	MESH:D013481	4846
24050620	Positive_Correlation	MESH:C002744	MESH:D011765
24050620	Association	MESH:D019331	4846
24050620	Association	MESH:C002744	4846
24050620	Negative_Correlation	MESH:C003402	4846
24050620	Positive_Correlation	MESH:D011765	MESH:D013481
24050620	Positive_Correlation	MESH:D011765	MESH:D003925

